These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 32818624

  • 1. Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis.
    Zhu X, Wang K, Chen Y.
    Toxicol In Vitro; 2020 Dec; 69():104973. PubMed ID: 32818624
    [Abstract] [Full Text] [Related]

  • 2. Ziyuglycoside II suppresses the aggressive phenotype of triple negative breast cancer cells through regulating Src/EGFR-dependent ITGB4/FAK signaling.
    Wang K, Zou P, Zhu X, Zhang T.
    Toxicol In Vitro; 2019 Dec; 61():104653. PubMed ID: 31525383
    [Abstract] [Full Text] [Related]

  • 3. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S, Lee J, Jeon M, Lee JE, Nam SJ.
    Oncotarget; 2016 Jan 12; 7(2):1544-58. PubMed ID: 26637807
    [Abstract] [Full Text] [Related]

  • 4. Tubeimoside V sensitizes human triple negative breast cancer MDA-MB-231 cells to anoikis via regulating caveolin-1-related signaling pathways.
    Wang K, Zhu X, Chen Y, Yin Y, Ma T.
    Arch Biochem Biophys; 2018 May 15; 646():10-15. PubMed ID: 29580948
    [Abstract] [Full Text] [Related]

  • 5. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
    Qin J, Tang J, Jiao L, Ji J, Chen WD, Feng GK, Gao YH, Zhu XF, Deng R.
    Life Sci; 2013 Nov 04; 93(18-19):655-63. PubMed ID: 24044886
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK, Kim HS, Jin T, Hwang EH, Jung M, Moon WK.
    BMC Cancer; 2016 Aug 02; 16():570. PubMed ID: 27484639
    [Abstract] [Full Text] [Related]

  • 7. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
    Jiang Q, Pan Y, Cheng Y, Li H, Liu D, Li H.
    Oncol Rep; 2016 Jul 02; 36(1):253-62. PubMed ID: 27175819
    [Abstract] [Full Text] [Related]

  • 8. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
    Yang HL, Thiyagarajan V, Shen PC, Mathew DC, Lin KY, Liao JW, Hseu YC.
    J Exp Clin Cancer Res; 2019 May 08; 38(1):186. PubMed ID: 31068208
    [Abstract] [Full Text] [Related]

  • 9. Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway.
    Zou Y, Xu L, Wang W, Zhu X, Lin J, Li H, Chen J, Xu W, Gao H, Wu X, Yin Z, Wang Q.
    Phytomedicine; 2024 Jul 08; 129():155714. PubMed ID: 38723526
    [Abstract] [Full Text] [Related]

  • 10. Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.
    Kim S, Lee J, You D, Jeong Y, Jeon M, Yu J, Kim SW, Nam SJ, Lee JE.
    Cell Physiol Biochem; 2018 Jul 08; 45(2):795-807. PubMed ID: 29414799
    [Abstract] [Full Text] [Related]

  • 11. HPW-RX40 restores anoikis sensitivity of human breast cancer cells by inhibiting integrin/FAK signaling.
    Chen IH, Shih HC, Hsieh PW, Chang FR, Wu YC, Wu CC.
    Toxicol Appl Pharmacol; 2015 Dec 01; 289(2):330-40. PubMed ID: 26386190
    [Abstract] [Full Text] [Related]

  • 12. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K, Son SH, Oh S, Jeon D, Kim H, Noh DY, Kim S, Shin I.
    Oncotarget; 2017 May 30; 8(22):35804-35823. PubMed ID: 28415760
    [Abstract] [Full Text] [Related]

  • 13. 3,4-Methylenedioxy-β-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing β1 integrin function and surface protein disulfide isomerase.
    Chen IH, Chang FR, Wu YC, Kung PH, Wu CC.
    Biochimie; 2015 Mar 30; 110():81-92. PubMed ID: 25593085
    [Abstract] [Full Text] [Related]

  • 14. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
    Hamurcu Z, Delibaşı N, Geçene S, Şener EF, Dönmez-Altuntaş H, Özkul Y, Canatan H, Ozpolat B.
    J Cancer Res Clin Oncol; 2018 Mar 30; 144(3):415-430. PubMed ID: 29288363
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis.
    Gautam J, Banskota S, Lee H, Lee YJ, Jeon YH, Kim JA, Jeong BS.
    Exp Mol Med; 2018 Sep 05; 50(9):1-14. PubMed ID: 30185799
    [Abstract] [Full Text] [Related]

  • 16. Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2+ breast cancer cells by attenuating nuclear factor-κB signaling.
    Xu G, Zhao H, Xu J, Zhang Y, Qi X, Shi A.
    J Ethnopharmacol; 2021 Apr 06; 269():113705. PubMed ID: 33346025
    [Abstract] [Full Text] [Related]

  • 17. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD, Hamurcu Z, Delibaşı N, Çınar V, Güler A, Gökçe S, Nurdinov N, Ozpolat B.
    Anticancer Agents Med Chem; 2021 Apr 06; 21(3):355-364. PubMed ID: 32767958
    [Abstract] [Full Text] [Related]

  • 18. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts.
    Horowitz JC, Rogers DS, Sharma V, Vittal R, White ES, Cui Z, Thannickal VJ.
    Cell Signal; 2007 Apr 06; 19(4):761-71. PubMed ID: 17113264
    [Abstract] [Full Text] [Related]

  • 19. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways.
    Jung O, Lee J, Lee YJ, Yun JM, Son YJ, Cho JY, Ryou C, Lee SY.
    Bioorg Med Chem Lett; 2016 Aug 15; 26(16):3963-7. PubMed ID: 27422337
    [Abstract] [Full Text] [Related]

  • 20. Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway.
    Chen M, Hu C, Guo Y, Jiang R, Jiang H, Zhou Y, Fu H, Wu M, Zhang X.
    Oncol Rep; 2018 Sep 15; 40(3):1339-1347. PubMed ID: 29956803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.